盐酸埃克替尼 T2307

Product Introduction
Bioactivity


英文名: Icotinib Hydrochloride

描述: Icotinib Hydrochloride (BPI-2009H) 是一种口服的基于喹唑啉的表皮生长因子受体 (EGFR) 抑制剂，IC50值为5 nM，具有潜在的抗肿瘤活性。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 12 mg/mL (28.04 mM)


关键字: Epidermal growth factor receptor | Icotinib Hydrochloride | HER1 | Inhibitor | EGFR | ErbB-1 | Icotinib | inhibit

相关产品: 1,5-Dihydroxyxanthone | EGFR-IN-9 | lavendustin C | Nezutatug | BMS-599626 | Astragaloside VI | PD 174265 | Nimotuzumab | WHI-P258 | EGFR/BRAFV600E-IN-2

相关库: Drug Repurposing Compound Library | FDA-Approved Kinase Inhibitor Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Cancer Clinical Compound Library | Kinase Inhibitor Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library | Tyrosine Kinase Inhibitor Library

盐酸埃克替尼 T2307信息由TargetMol中国为您提供，如您想了解更多关于盐酸埃克替尼 T2307报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途